You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiotensin(1-7)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aortic Stenosis Trial in Québec, Odense (Angiotensin Receptor Blockers, Placebo)

Recruiting
  • Aortic Stenosis
  • Angiotensin Receptor Blockers
  • Placebo
  • Québec, Quebec, Canada
  • +1 more
Mar 28, 2022

Hypertension Trial in Thessaloniki, London (Anti-hypertensive Medication -)

Completed
Has Results
  • Hypertension
  • Anti-hypertensive Medication -
  • Thessaloniki, Greece
  • +1 more
Mar 5, 2021

Abdominal Aortic Aneurysm Trial in United Kingdom (perindopril arginine, amlodipine 5mgs, )

Completed
Has Results
  • Abdominal Aortic Aneurysm
  • perindopril arginine
  • +2 more
  • Bournemouth, United Kingdom
  • +8 more
Jan 5, 2021

Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)

Terminated
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Duarte, California
  • +9 more
Dec 7, 2020

Narcolepsy Type 1 Trial in Marseille (7T MRI)

Not yet recruiting
  • Narcolepsy Type 1
  • 7T MRI
  • Marseille, France
    Service Epileptologie et Rythmologie Cérébrale, Centre du Sommei
Jul 22, 2023

Clearance of Vasoactive Metabolites With Blood Purification

Not yet recruiting
  • Critically Ill Patients
    • Garches, France
    • +1 more
    Oct 27, 2023

    Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder Trial in Kelowna (Hyperoxic Hypercapnic Ventilatory Response

    Completed
    • Sleep Disordered Breathing
    • +3 more
    • Hyperoxic Hypercapnic Ventilatory Response Test
    • +5 more
    • Kelowna, British Columbia, Canada
      University of British Columbia
    Sep 2, 2020

    Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

    Completed
    • Cardiac Failure
      • Wetzikon, Switzerland
        GZO Regional Health Center
      Jul 13, 2021

      Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

      Completed
      Has Results
      • Hypertension
      • COVID-19
      • Angiotensin converting enzyme inhibitor
      • +2 more
      • Kiev, Please Select, Ukraine
        Medical Practice Prof D.Ivanov
      Feb 16, 2022

      Ulcus Cruris, Ecthyma, Ulcer, Leg Trial in Zurich (IMP2 (lidocaine-23%-tetracaine-7% gel), IMP1 (EMLA 5% cream))

      Recruiting
      • Ulcus Cruris
      • +3 more
      • IMP2 (lidocaine-23%-tetracaine-7% gel)
      • IMP1 (EMLA 5% cream)
      • Zurich, Switzerland
        Department of Dermatology, University Hospital of Zurich, Switze
      Jun 5, 2023

      Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)

      Not yet recruiting
      • Breast Cancer
      • +12 more
      • Opole, Opolskie, Poland
      • +3 more
      Jul 15, 2022

      Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +10 more
      • (no location specified)
      Feb 17, 2023

      Hypertension, Insulin Resistance Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

      Active, not recruiting
      • Hypertension
      • Insulin Resistance
      • Para-aminohippuric Acid
      • +2 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Feb 28, 2022

      Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Recombinant Interleukin-7
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 26, 2023

      HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

      Active, not recruiting
      • HIV-1-infection
      • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam University Medical Centers, location AMC
      Jan 31, 2023

      Hypertension, Atherosclerosis, Diabetes, Type 2 Trial in Seongnam (Fimasartan)

      Recruiting
      • Hypertension
      • +3 more
      • Seongnam, Gyeonggi, Korea, Republic of
        Seoul National University Bundang Hospital
      Dec 27, 2021

      Systemic Right Ventricle, Heart Failure Trial in Montreal (Sacubitril / Valsartan Oral Tablet, Placebo)

      Active, not recruiting
      • Systemic Right Ventricle
      • Heart Failure
      • Sacubitril / Valsartan Oral Tablet
      • Placebo
      • Montreal, Quebec, Canada
        Montreal Heart Institute
      Dec 21, 2022

      Advanced Solid Tumor Trial (7MW3711 for injection)

      Not yet recruiting
      • Advanced Solid Tumor
      • 7MW3711 for injection
      • (no location specified)
      Aug 18, 2023

      HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

      Not yet recruiting
      • HPV Infection
      • HPV-Related Cervical Carcinoma
      • FluBHPVE6E7
      • Placebo
      • (no location specified)
      Apr 24, 2023

      Dyslexia Trial in Paris (behavioral measures, Electrophysiological measures, Training 1)

      Not yet recruiting
      • Dyslexia
      • behavioral measures
      • +3 more
      • Paris, France
        Institut de l'Audition
      Aug 9, 2023

      Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant

      Recruiting
      • Breast Carcinoma
      • +2 more
      • Recombinant human IL-7-hyFc (NT-I7)
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      The Right Care, for Right Patient, at Right Time, by Right

      Not yet recruiting
      • Ambulatory Care
      • +3 more
      • On-site recruitment (information and consent) following a random sampling recruitment schedule
      • +2 more
      • Kingston, Ontario, Canada
      • +6 more
      May 26, 2023

      Diffuse Large B-cell Lymphoma Trial in Hangzhou, Ningbo (CD19-7×19 CAR-T combined with Tislelizumab)

      Recruiting
      • Diffuse Large B-cell Lymphoma
      • CD19-7×19 CAR-T combined with Tislelizumab
      • Hangzhou, Zhejiang, China
      • +1 more
      Dec 12, 2022

      Brain Metabolism Observed at 7 Tesla

      Recruiting
      • Glut1 Deficiency Syndrome 1
      • +6 more
      • Magnetic resonance imaging
      • Dallas, Texas
        UT Southwestern Medical Center
      Aug 24, 2022

      Advanced Solid Tumor Trial in China (7MW3711 for injection)

      Not yet recruiting
      • Advanced Solid Tumor
      • 7MW3711 for injection
      • Changsha, Hunan, China
      • +3 more
      Aug 18, 2023